Xiaoyang Li

机构：Central South University, Shanghai University of Engineering Science, Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Gansu University of Traditional Chinese Medicine, Hunan Cancer Hospital · ORCID：0000-0001-8316-3013

发表论文 39 篇 · 总被引 1645 次 · h-index 14

代表论文

• Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota (2021 · Signal Transduction and Targeted Therapy · 被引 316)
• Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19 (2021 · ACS Nano · 被引 128)
• Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy (2022 · Acta Biomaterialia · 被引 40)
• Natural Products from Marine-Derived Fungi with Anti-Inflammatory Activity (2024 · Marine Drugs · 被引 30)
• Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034 (2024 · Cancer Control · 被引 25)
• Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer (2024 · International Journal of Biological Macromolecules · 被引 13)